{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T20:19:48Z","timestamp":1774383588620,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T00:00:00Z","timestamp":1695168000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"DOI":"10.1007\/s10238-023-01173-3","type":"journal-article","created":{"date-parts":[[2023,9,20]],"date-time":"2023-09-20T12:02:26Z","timestamp":1695211346000},"page":"5345-5353","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessment of \u03b19\u03b21 \u0131ntegr\u0131n as a new d\u0131agnost\u0131c and therapeut\u0131c target \u0131n Behcet\u2019s d\u0131sease"],"prefix":"10.1007","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3419-1995","authenticated-orcid":false,"given":"P\u0131nar","family":"Ellergezen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0298-4157","authenticated-orcid":false,"given":"Belk\u0131s Nihan","family":"Co\u015fkun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0307-3486","authenticated-orcid":false,"given":"G\u00fclce Sevdar","family":"\u00c7e\u00e7en","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3612-3232","authenticated-orcid":false,"given":"Zeynep Y\u0131lmaz","family":"Bozkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2651-2034","authenticated-orcid":false,"given":"Harun","family":"A\u011fca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8645-2670","authenticated-orcid":false,"given":"H\u00fcseyin Ediz","family":"Dalk\u0131l\u0131\u00e7","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0764-6376","authenticated-orcid":false,"given":"Sinan","family":"\u00c7avun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,20]]},"reference":[{"key":"1173_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/nrrheum.2018.3","volume":"14","author":"H Yaz\u0131c\u0131","year":"2018","unstructured":"Yaz\u0131c\u0131 H, Seyahi E, Hatemi G, et al. Beh\u00e7et syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14:119.","journal-title":"Nat Rev Rheumatol"},{"key":"1173_CR2","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1111\/1346-8138.13381","volume":"43","author":"E Alpsoy","year":"2016","unstructured":"Alpsoy E. Beh\u00e7et\u2019s disease: A comprehensive review focusing on epidemiology, etiology and clinical features, and management of mucocutaneous lesions. J Dermatol. 2016;43:620\u201332.","journal-title":"J Dermatol"},{"key":"1173_CR3","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s00281-015-0502-8","volume":"37","author":"A G\u00fcl","year":"2015","unstructured":"G\u00fcl A. Pathogenesis of Beh\u00e7et\u2019s disease: autoinflammatory features and beyond. Semin Immunopathol. 2015;37:413\u20138.","journal-title":"Semin Immunopathol"},{"key":"1173_CR4","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1038\/s41390-020-01177-9","volume":"89","author":"OJ Mezu-Ndubuisi","year":"2021","unstructured":"Mezu-Ndubuisi OJ, Maheshwari A. The role of integrins in inflammation and angiogenesis. Pediatr Res. 2021;89:1619\u201326.","journal-title":"Pediatr Res"},{"issue":"2","key":"1173_CR5","doi-asserted-by":"publisher","first-page":"194","DOI":"10.4161\/cam.4.2.10900","volume":"4","author":"SK Gupta","year":"2010","unstructured":"Gupta SK, Vlahakis NE. Integrin alph\u03b19beta1: Unique signaling pathways reveal diverse biological roles. Cell Adh Migr. 2010;4(2):194\u20138.","journal-title":"Cell Adh Migr"},{"issue":"1","key":"1173_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12079-017-0413-7","volume":"12","author":"S Kon","year":"2018","unstructured":"Kon S, Ueda T. The role of \u03b19\u03b21 integrin and its ligands in developing autoimmune diseases. J Cell Commun Signal. 2018;12(1):333\u201342.","journal-title":"J Cell Commun Signal"},{"key":"1173_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a004994","author":"ID Campbell","year":"2023","unstructured":"Campbell ID, Humphries MJ. Integrin Structure, Activation, and Interactions. Cold Spring Harb Perspect Biol. 2023. https:\/\/doi.org\/10.1101\/cshperspect.a004994.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"1173_CR8","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/gb-2007-8-5-215","volume":"8","author":"Y Takada","year":"2007","unstructured":"Takada Y, Ye X, Simon S. The integrins. Genome Biol. 2007;8:215.","journal-title":"Genome Biol"},{"key":"1173_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.638400","volume":"12","author":"S Xu","year":"2021","unstructured":"Xu S, Zhang T, Cao Z, et al. Integrin-\u03b19\u03b21 as a novel therapeutic target for refractory diseases: recent progress and insights. Front Immunol. 2021;12: 638400.","journal-title":"Front Immunol"},{"issue":"2","key":"1173_CR10","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3390\/cells12020324","volume":"12","author":"I Tvaroska","year":"2023","unstructured":"Tvaroska I, Kozmon S, Kona J. Molecular modeling insights into the structure and behavior of Integrins: a review. Cells. 2023;12(2):324.","journal-title":"Cells"},{"key":"1173_CR11","first-page":"1078","volume":"335","author":"International Study Group For Behcet's Disease","year":"1990","unstructured":"International Study Group For Behcet\u2019s Disease. Criteria for diagnosis of Behcet\u2019s disease. Lancet. 1990;335:1078\u201380.","journal-title":"Lancet"},{"issue":"1","key":"1173_CR12","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1093\/rheumatology\/keg453","volume":"43","author":"G Lawton","year":"2004","unstructured":"Lawton G, Bhakta BB, Chamberlain MA, Tennant A. The Behcet\u2019s disease activity index. Rheumatology. 2004;43(1):73\u20138.","journal-title":"Rheumatology"},{"key":"1173_CR13","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.3389\/fimmu.2019.01067","volume":"10","author":"P Leccese","year":"2019","unstructured":"Leccese P, Alpsoy E. Beh\u00e7et\u2019s Disease: An Overview of Etiopathogenesis. Front Immunol. 2019;10:1067.","journal-title":"Front Immunol"},{"key":"1173_CR14","doi-asserted-by":"publisher","first-page":"8015","DOI":"10.4049\/jimmunol.0900725","volume":"182","author":"M Kanayama","year":"2009","unstructured":"Kanayama M, Kurotaki D, Mor\u0131moto J, et al. Alph\u03b19 integrin and its ligands constitute critical joint microenvironments for the development of autoimmune arthritis. J Immunol. 2009;182:8015\u201325.","journal-title":"J Immunol"},{"key":"1173_CR15","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1083\/jcb.123.5.1289","volume":"123","author":"EL Palmer","year":"1993","unstructured":"Palmer EL, Ruegg C, Ferrando R, et al. Sequence and tissue distribution of the integrin alpha nine subunits, a novel partner of beta one that is widely distributed in epithelia and muscle. J Cell Biol. 1993;123:1289\u201397.","journal-title":"J Cell Biol"},{"key":"1173_CR16","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1002\/art.1780400402","volume":"40","author":"WP Arend","year":"1997","unstructured":"Arend WP. The pathophysiology and treatment of rheumatoid arthritis. Arthritis Rheum. 1997;40:595\u20137.","journal-title":"Arthritis Rheum"},{"issue":"10","key":"1173_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.852878","volume":"18","author":"S Banerjee","year":"2022","unstructured":"Banerjee S, Nara R, Chakraborty S, et al. Integrin regulated autoimmune disorders: understanding the role of mechanical forces in autoimmunity. Front Cell Dev Biol. 2022;18(10): 852878.","journal-title":"Front Cell Dev Biol"},{"issue":"6","key":"1173_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1186\/ar4105","volume":"14","author":"TH Page","year":"2012","unstructured":"Page TH, Charles PJ, Piccinini AM, et al. Raised circulating tenascin-C in rheumatoid arthritis. Arthritis Res Ther. 2012;14(6):260.","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"1173_CR19","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1002\/art.10143","volume":"46","author":"S Ohshima","year":"2002","unstructured":"Ohshima S, Kobayashi H, Yamaguchi N, et al. Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis. Arthritis Rheum. 2002;46(4):1094\u2013101.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1173_CR20","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s12079-017-0413-7","volume":"12","author":"S Kon","year":"2018","unstructured":"Kon S, Ueda T. The role of alph\u03b19beta1 integrin and its ligands in developing autoimmune diseases. J Cell Commun Signal. 2018;12(1):333\u201342.","journal-title":"J Cell Commun Signal"},{"key":"1173_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.ejphar.2018.06.021","volume":"833","author":"S Sugahara","year":"2018","unstructured":"Sugahara S, Hanaoka K, Yamamoto N. Integrin, alph\u03b19 subunit blockade suppresses collagen-induced arthritis with minimal systemic immunomodulation. Eur J Pharmacol. 2018;833:320\u20137.","journal-title":"Eur J Pharmacol"},{"key":"1173_CR22","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1126\/science.1062960","volume":"294","author":"D Chabas","year":"2001","unstructured":"Chabas D, Se Baranzini, Mitchell D, et al. The influence of the proinflammatory cytokine, osteopontin, on autoimmune demyelinating disease. Science. 2001;294:1731\u20135.","journal-title":"Science"},{"key":"1173_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jneuroim.2016.12.001","volume":"302","author":"M Momcilovic","year":"2017","unstructured":"Momcilovic M, Stamenkovic V, Jovanovic M. Tenascin-C deficiency protects mice from experimental autoimmune encephalomyelitis. J Neuroimmunol. 2017;302:1\u20136.","journal-title":"J Neuroimmunol"},{"key":"1173_CR24","first-page":"935","volume-title":"Comprehensive medicinal chemistry II","author":"JS Skotnicki","year":"2007","unstructured":"Skotnicki JS, Huryn DM. Therapeutic areas II: cancer, infectious diseases, inflammation & immunology, and dermatology. In: Taylor JB, Triggle DJ, editors. Comprehensive medicinal chemistry II. Elsevier; 2007. p. 935\u201385."},{"issue":"3","key":"1173_CR25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1182\/blood-2005-07-2692","volume":"107","author":"EA Ross","year":"2006","unstructured":"Ross EA, Douglas MR, Wong SH, et al. Interaction between integrin \u03b19 \u03b21 and vascular cell adhesion molecule-1 (VCAM-1) inhibits neutrophil apoptosis. Blood. 2006;107(3):1178\u201383.","journal-title":"Blood"},{"issue":"2","key":"1173_CR26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1083\/jcb.145.2.413","volume":"145","author":"Y Taooka","year":"1999","unstructured":"Taooka Y, Chen J, Yednock T, et al. The integrin \u03b19\u03b21 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol. 1999;145(2):413\u201320.","journal-title":"J Cell Biol"},{"issue":"9","key":"1173_CR27","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1161\/01.RES.0000266662.98355.66","volume":"100","author":"I Staniszewska","year":"2007","unstructured":"Staniszewska I, Zaveri S, Del Valle L, et al. Interaction of alph\u03b19beta1 integrin with thrombospondin-1 promotes angiogenesis. Circ Res. 2007;100(9):1308\u201316.","journal-title":"Circ Res"},{"issue":"2","key":"1173_CR28","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1007\/s10549-010-1085-7","volume":"128","author":"M Koch","year":"2011","unstructured":"Koch M, Husse\u0131n F, Woeste A, et al. CD36-mediated activation of endothelial cell apoptosis by an N-terminal recombinant fragment of thrombospondin-2 inhibits breast cancer growth and metastasis in vivo. Breast Cancer Res Treat. 2011;128(2):337\u201346.","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"1173_CR29","doi-asserted-by":"publisher","first-page":"4704","DOI":"10.1111\/j.1742-4658.2011.08346.x","volume":"278","author":"AM Belkin","year":"2011","unstructured":"Belkin AM. Extracellular TG2: emerging functions and regulation. FEBS J. 2011;278(24):4704\u201316.","journal-title":"FEBS J"},{"key":"1173_CR30","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/ar3899","volume":"14","author":"A Lauzier","year":"2012","unstructured":"Lauzier A, Charbonneau M, Paquette M, et al. Transglutaminase 2 cross-linking activity is linked to invadopodia formation and cartilage breakdown in arthritis. Arthritis Res Ther. 2012;14:159.","journal-title":"Arthritis Res Ther"},{"key":"1173_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.jid.5701248","volume":"128","author":"EJ Muller","year":"2008","unstructured":"Muller EJ, Williamson L, Kolly C, et al. Outside-in signaling through integrins and cadherins: a central mechanism to control epidermal growth and differentiation? J Invest Dermatol. 2008;128:501\u201316.","journal-title":"J Invest Dermatol"},{"key":"1173_CR32","doi-asserted-by":"publisher","first-page":"4072","DOI":"10.1073\/pnas.061307098","volume":"98","author":"CV Denis","year":"2001","unstructured":"Denis CV, Andre P, Saffaripour S, et al. Defect in the regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci. 2001;98:4072\u20137.","journal-title":"Proc Natl Acad Sci"},{"key":"1173_CR33","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s00018-014-1743-8","volume":"72","author":"M Bryckaert","year":"2015","unstructured":"Bryckaert M, Rosa JP, Denis CV, et al. Of von Willebrand factor and platelets. Cell Mol Life Sci. 2015;72:307\u201326.","journal-title":"Cell Mol Life Sci"},{"key":"1173_CR34","first-page":"1412","volume":"124","author":"TA Springer","year":"2014","unstructured":"Springer TA. von Willebrand factor. Jedi knight of the bloodstream Blood. 2014;124:1412\u201325.","journal-title":"Jedi knight of the bloodstream Blood"},{"key":"1173_CR35","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1182\/blood-2010-01-264507","volume":"117","author":"RD Starke","year":"2011","unstructured":"Starke RD, Ferraro F, Paschalaki KE, et al. Endothelial von Willebrand factor regulates angiogenesis. Blood. 2011;117:1071\u201380.","journal-title":"Blood"},{"issue":"2","key":"1173_CR36","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/S0049-3848(07)70132-9","volume":"120","author":"V Terraube","year":"2007","unstructured":"Terraube V, Marx I, Denis CV. Role of von Willebrand factor in tumor metastasis. Thromb Res. 2007;120(2):64\u201370.","journal-title":"Thromb Res"},{"issue":"1","key":"1173_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s41927-020-00172-1","volume":"5","author":"M Kiafar","year":"2021","unstructured":"Kiafar M, Faezi ST, Kasaeian A, et al. Diagnosis of Behcet\u2019s disease: clinical characteristics, diagnostic criteria, and differential diagnoses. BMC Rheumatol. 2021;5(1):2.","journal-title":"BMC Rheumatol"},{"key":"1173_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14638","volume":"75","author":"D Tezcan","year":"2021","unstructured":"Tezcan D, K\u00f6rez MK, G\u00fclcemal S, et al. Evaluation of the diagnostic performance of hematological parameters in Beh\u00e7et\u2019s disease. Int J Clin Pract. 2021;75: e14638.","journal-title":"Int J Clin Pract"},{"key":"1173_CR39","unstructured":"- Okatan IE, Torgutalp M, Ate\u015f A, et al. Relationship between disease activity and neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, and mean platelet volume in Behcet's disease. Ann Rheum Dis 25(6): 510\u2013516."},{"issue":"52","key":"1173_CR40","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018443","volume":"98","author":"MM Zunni Zhang","year":"2019","unstructured":"Zunni Zhang MM, Qisheng Su MM, Liqian Zhang MM, et al. Diagnostic value of hemoglobin and neutrophil-to-lymphocyte ratio in Behcet Disease. Medicine (Baltimore). 2019;98(52): e18443.","journal-title":"Medicine (Baltimore)"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-023-01173-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-023-01173-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T16:16:17Z","timestamp":1702743377000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-023-01173-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,20]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1173"],"URL":"https:\/\/doi.org\/10.1007\/s10238-023-01173-3","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,20]]},"assertion":[{"value":"28 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No potential conflict of interest was reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}